Clinical Trial: Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetes Mellitus, Type 2
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of MK-2828 in Participants With Type 2 Diabetes
Brief Summary:
The purpose of this study is to learn about the safety and if people tolerate a study medicine called MK-2828. The study will also measure what happens to MK-2828 in the body of a person with type 2 diabetes (T2D) over time (pharmacokinetic or PK study), and how it affects the amount of high-sensitivity C-reactive protein (hsCRP) in a person's blood.
Read more